Global EYLEA Drogenmarkt wird durch Indikation (Wet Age-Related Macular Degeneration (Wet AMD), Diabetic Retinopathy (DR), Diabetic Macular Edema (DME), Retinal Vein Occlusion (RVO), Myopic Choroidal Neovascularization (mCNV), and Others), By End User (Hospitals, Ophthalmic Clinics, and Others America), By End User Der Bericht bietet den Wert (in Mrd. USD) für die oben genannten Segmente.
Bayer, Regeneron Pharmaceuticals, Coherus BioSciences, Inc. und Klinge Biopharma.
Global EYLEA Drug Market